Please ensure Javascript is enabled for purposes of website accessibility

3 Horrendous Health-Care Stocks This Week

By Keith Speights - Feb 8, 2014 at 8:00AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Which health-care stocks had as lousy of a week as Broncos fans? Here are 3 big losers from the past few days.

What kind of week do you suppose Peyton Manning, star quarterback of the Denver Broncos, had this week? After the horrible Super Bowl loss to the Seattle Seahawks, it probably wasn't too great for Manning and the rest of the Denver team.

Shareholders of these three health-care stocks can commiserate with the Broncos. All three plunged by double-digit percentages this week. Find out which companies landed at the bottom of the health-care heap and what happened by watching the following slideshow.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Vanda Pharmaceuticals Inc. Stock Quote
Vanda Pharmaceuticals Inc.
VNDA
$10.22 (4.39%) $0.43
Medidata Solutions, Inc. Stock Quote
Medidata Solutions, Inc.
MDSO
Affymetrix Inc. Stock Quote
Affymetrix Inc.
AFFX.DL

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
356%
 
S&P 500 Returns
124%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 05/29/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.